NewEdge Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.83M Sell
14,484
-500
-3% -$63.3K 0.01% 978
2025
Q1
$1.92M Buy
14,984
+1,195
+9% +$153K 0.01% 885
2024
Q4
$1.82M Buy
13,789
+1,893
+16% +$250K 0.01% 866
2024
Q3
$1.73M Buy
11,896
+263
+2% +$38.3K 0.01% 851
2024
Q2
$1.6M Buy
11,633
+1,944
+20% +$267K 0.01% 853
2024
Q1
$1.33M Sell
9,689
-24
-0.2% -$3.29K 0.01% 856
2023
Q4
$1.32M Sell
9,713
-2,229
-19% -$303K 0.01% 822
2023
Q3
$1.46M Sell
11,942
-718
-6% -$87.8K 0.02% 707
2023
Q2
$1.61M Sell
12,660
-4,277
-25% -$543K 0.02% 670
2023
Q1
$2.19M Sell
16,937
-4,679
-22% -$606K 0.03% 504
2022
Q4
$1.83M Buy
21,616
+5,747
+36% +$485K 0.05% 345
2022
Q3
$1.86M Sell
15,869
-16,634
-51% -$1.95M 0.03% 450
2022
Q2
$3.82M Buy
32,503
+18,726
+136% +$2.2M 0.06% 287
2022
Q1
$1.8M Buy
13,777
+1,445
+12% +$188K 0.03% 451
2021
Q4
$1.88M Buy
12,332
+5
+0% +$763 0.03% 474
2021
Q3
$1.99M Buy
12,327
+6,659
+117% +$1.08M 0.05% 320
2021
Q2
$928K Sell
5,668
-10
-0.2% -$1.64K 0.02% 515
2021
Q1
$855K Sell
5,678
-231
-4% -$34.8K 0.03% 499
2020
Q4
$895K Buy
5,909
+174
+3% +$26.4K 0.03% 438
2020
Q3
$777K Buy
5,735
+578
+11% +$78.3K 0.03% 449
2020
Q2
$705K Buy
5,157
+1,994
+63% +$273K 0.03% 456
2020
Q1
$341K Sell
3,163
-1,394
-31% -$150K 0.02% 563
2019
Q4
$549K Sell
4,557
-283
-6% -$34.1K 0.02% 495
2019
Q3
$486K Buy
4,840
+1,861
+62% +$187K 0.02% 495
2019
Q2
$325K Sell
2,979
-564
-16% -$61.5K 0.02% 503
2019
Q1
$396K Sell
3,543
-353
-9% -$39.5K 0.03% 452
2018
Q4
$376 Buy
3,896
+1,505
+63% +$145 0.02% 433
2018
Q3
$292K Sell
2,391
-57
-2% -$6.96K 0.02% 500
2018
Q2
$271 Buy
2,448
+242
+11% +$27 0.02% 435
2018
Q1
$226K Buy
+2,206
New +$226K 0.03% 434
2017
Q3
Sell
-150
Closed -$15.5K 703
2017
Q2
$15.5K Buy
+150
New +$15.5K ﹤0.01% 814